其实我个人对这个药觉得还是不错的，因为我们有一部分病人是比较难治的，目

In fact, I personally feel that this drug is still good, because some of our patients are more difficult to treat. The current methods even if multi-target treatment are not effective afterwards. The disease of these patients is not relieved, resulting in the quality of life of these patients. The loss of disease, or the emergence of life-threatening problems, so I think in this kind of treatment dilemma, belyumumab provides a new perspective for treatment. I think it is good to give patients a new hope.

In fact, I personally feel that this medicine is still good, because we have some patients are more difficult to treat, the current means even after multi-target treatment is not good, these patients' diseases do not ease, resulting in the loss of quality of life of these patients, or life-threatening problems, so I think in this treatment dilemma, Bellevue mono-resistance provides a new treatment perspective, I think it is good to give patients a new hope.

As a matter of fact, I personally think this medicine is good because some of our patients are difficult to treat. Even if the current methods are multi-target treatment, the effect is not good after the treatment. If the disease of these patients is not alleviated, the quality of life of these patients will be lost, or life-threatening problems will appear. Therefore, I think that under the difficult situation of this treatment, Bailey is particularly single I think it's good to give patients a new hope.<br>